Process for production of a soluble and insoluble collagen product from mammalian dermis tissue
12351620 ยท 2025-07-08
Assignee
Inventors
Cpc classification
C07K14/78
CHEMISTRY; METALLURGY
International classification
A61K38/39
HUMAN NECESSITIES
A61K47/42
HUMAN NECESSITIES
C07K14/78
CHEMISTRY; METALLURGY
Abstract
A process for the production of a soluble collagen product and an insoluble collagen product from mammalian dermis tissue is described. The tissue may initially be processed to remove the epidermis and adipose tissue and then minced into small pieces. The process includes washing the minced dermis in an enzymatic solution, such as an amylase solution followed by homogenizing the amylased tissue. The soluble and insoluble collagen is then extracted from the homogenized tissue and subsequently separated into distinct soluble and insoluble fractions. The process produces collagen with high Dalton values that can subsequently be combined to produce a mixed composite collagen product. Also, the extracted collagen may be used as an integral composite collagen before separation.
Claims
1. A process for the methacrylation of a soluble collagen from an extracted collagen from mammalian dermis tissue comprising: a) providing said extracted collagen including said soluble collagen and an insoluble collagen; b) salt precipitation of the soluble collagen to isolate a type I soluble collagen and further comprising methacrylation of the type I soluble collagen, comprising: c) providing a methacrylic anhydride solution: d) combining the type I soluble collagen with an acid to produce a type I soluble collagen solution; wherein the molarity of acid is between 0.005 M to 5 M; e) adding base to the type I soluble collagen solution to produce a non-pH adjusted collagen solution; f) providing buffer and adding said buffer to the non-pH adjusted collagen solution to adjust the pH between 7.0 and 8.0, producing a pH adjusted type I soluble collagen solution; g) adding the methacrylic anhydride solution to the pH adjusted type I soluble collagen solution to produce a type I soluble collagen methacrylic anhydride solution: h) agitating the type I soluble collagen methacrylic anhydride solution for a methacrylation time of at least 2 hours at a temperature between 0 C. to 20 C.; i) centrifuging the type I soluble collagen methacrylic anhydride solution from step (h) to collect supernatant containing type I soluble collagen methacrylate; and j) dialyzing the supernatant containing type I soluble collagen methacrylate against acid for at least 1 day to produce methacrylated type I soluble collagen: k) lyophilization of the methacrylated soluble type I collagen comprising freezing the methacrylated soluble type I collagen and then heating the frozen methacrylated soluble type I collagen to a lyophilization temperature of at least 10 C. (50 F.) while drawing vacuum on the methacrylated soluble type I collagen, wherein a vacuum pressure is at least 100 mTorr: wherein a degree of methacrylation of the methacrylated type I soluble collagen produced is between 10% to 95%.
2. The process of claim 1, wherein the minced mammalian dermis tissue has a size of no more than 10 mm.
3. The process of claim 1, wherein the dialysis further comprises providing a dialysis bag with a molecular weight cutoff (MWCO) ranging from 1 kDa to 100 kDa and passing the supernatant containing type I soluble collagen methacrylate through said dialysis bag.
Description
BRIEF DESCRIPTION OF SEVERAL VIEWS OF THE DRAWINGS
(1) The accompanying drawings are included to provide a further understanding of the invention and are incorporated in and constitute a part of this specification, illustrate embodiments of the invention, and together with the description serve to explain the principles of the invention.
(2)
(3)
(4)
(5)
(6) Corresponding reference characters indicate corresponding parts throughout the several views of the figures. The figures represent an illustration of some of the embodiments of the present invention and are not to be construed as limiting the scope of the invention in any manner. Some of the figures may not show all of the features and components of the invention for ease of illustration, but it is to understood that where possible, features and components from one figure may be an included in the other figures. Further, the figures are not necessarily to scale, some features may be exaggerated to show details of particular components. Therefore, specific structural and functional details disclosed herein are not to be interpreted as limiting, but merely as a representative basis for teaching one skilled in the art to variously employ the present invention.
DETAILED DESCRIPTION OF THE ILLUSTRATED EMBODIMENTS
(7) As used herein, the terms comprises, comprising, includes, including, has, having or any other variation thereof, are intended to cover a non-exclusive inclusion. For example, a process, method, article, or apparatus that comprises a list of elements is not necessarily limited to only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus. Also, use of a or an are employed to describe elements and components described herein. This is done merely for convenience and to give a general sense of the scope of the invention. This description should be read to include one or at least one and the singular also includes the plural unless it is obvious that it is meant otherwise.
(8) Certain exemplary embodiments of the present invention are described herein and are illustrated in the accompanying figures. The embodiments described are only for purposes of illustrating the present invention and should not be interpreted as limiting the scope of the invention. Other embodiments of the invention, and certain modifications, combinations and improvements of the described embodiments, will occur to those skilled in the art and all such alternate embodiments, combinations, modifications, improvements are within the scope of the present invention.
(9) As shown in
(10) As shown in
(11) As shown in
(12) The first layer 40 may be oriented in alignment with the second layer and/or the additive sheet 86. The collagen fibers of the first layer may be configured an offset angle to the collagen fibers in the second layer, or to a feature of the additive, such as fiber or strand or weave orientation. An offset angle may be about 20 degrees or more, about 45 degrees or more, about 60 degrees or more, about 75 degrees or more or about orthogonal, or 90 degrees. In an exemplary embodiment the collagen fibers of the first layer are configured orthogonal, about 90 degrees from collagen fibers of the second layer. A composite collagen product may have a plurality of layers of composite collagen product and each layer may be configured an offset angle, such as about 90 degrees from each adjacent layer. As described herein the collagen fibers of a composite collagen product may be oriented through processing such as by stretching and locked into position during freezing, lyophilization and/or crosslinking.
(13) The collagen fibers 18 and 18 may be oriented in different directions, wherein the first collagen fibers 18 of the first layer 40 of composite collagen 11 are oriented at an offset angle to the collagen fibers 18 of the second layer 50 of composite collagen 11. The offset angle may be 10 degrees or more, about 22.5 degrees or more, about 45 degrees or more, or about 90 degrees or more, or orthogonal. An orthogonal orientation may provide a higher composite strength in the composite collagen product 10.
(14) Referring to
(15) A shaped composite collagen product may include an additive 80, which may be an integral additive 82, such as particles, fibers or chemical compounds that are mixed with the composite collagen or may be an additive product 84, such as an additive sheet 86, a thin layer of additive material, or tube or other form or shaped material that the collagen is combined with, such as by coating or imbibing into or coupling thereto. An additive may be an organic material, such as elastin, dermis or synthetic material, such as a polymeric support scaffold, including a microporous support scaffold, porous membrane, polyethylene, polytetrafluoroethylene. A polymer may include a homopolymer, co-polymer and may be a thermoplastic or thermoset material. An additive 80, such as an additive product 84 and particularly an additive sheet 86 may be a bioresorbable material such as a bioresorbable polymer. A bioresorbable material is resorbed by the body when implanted, such as by enzymatic breakdown, pH, temperature, physical breakdown and the like. An additive may be fibers that may be an integral additive and mixed in with the composite collagen or may form a layer on a surface of a composite collagen product. Fibers may be bundled and may be aligned for increased strength and the collagen may coat or be coupled to the fibers. Also, fibers may be configured as a layer with a composite collagen product and again, the fibers in this layer may be oriented or in a random orientation. Fibers may be organic fibers, a bioresorbable fiber or a synthetic fiber, for example.
(16) Referring to
(17) A composite collagen product 10 having a plurality of layers, may be coupled together, wherein an a first layer 40 is coupled to a second layer 50 by an adhesive, suturing, compressing such as free compression wherein the composite collagen product is unrestrained around a perimeter, or compression within a restrain, glueing, fusing including pressing with heat and the like.
(18) As shown in
(19) It will be apparent to those skilled in the art that various modifications, combinations and variations can be made in the present invention without departing from the scope of the invention. Specific embodiments, features and elements described herein may be modified, and/or combined in any suitable manner. Thus, it is intended that the present invention cover the modifications, combinations and variations of this invention provided they come within the scope of the appended claims and their equivalents.